Myristoyl Tetrapeptide-12 promotes dermal papilla cell proliferation and modulates wnt/β-catenin signaling and androgen receptor conformational dynamics
Frontiers in Pharmacology · 09.11.2026 · 17
DOI: 10.3389/fphar.2026.1996340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 09.11.2026. Verfasst von Jianing Liu und 6 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Dermal papilla cells regulate hair follicle growth, yet bioactive peptides that influence both pro-growth signaling and androgen receptor (AR)-associated regulation remain poorly characterized. This study evaluated the effects of Myristoyl Tetrapeptide-12 (MT12) on human dermal papilla cell function and its potential interaction with the AR ligand-binding domain (AR-LBD).
Methods
Human dermal papilla cells were treated with MT12, with bicalutamide as a pharmacological reference. Cell viability, proliferation, and expression of Wnt/ β -catenin-related, AR-associated, and hair-growth-related genes were assessed by CCK-8, EdU incorporation, and quantitative PCR, respectively. Molecular docking, 500-ns molecular dynamics simulations, and residue communication-network analysis were used to characterize MT12–AR-LBD interactions.
Results
MT12 showed good cytocompatibility and significantly increased dermal papilla cell proliferation, with EdU-positive cells increasing from approximately 5% in controls to 18%–22% after treatment. MT12 increased CTNNB1 and WNT5A expression and reduced DKK1 expression, together with changes in AR , TGF- β 1 , and PEDF/SERPINF1 transcripts. Computational analyses indicated that MT12 remained associated with the AR-LBD binding pocket and altered local flexibility, conformational sampling, correlated residue motions, and intradomain communication. A recurrent ASN705–MET895–ILE898 route linked the ligand-binding region to the H12/AF-2 regulatory region.
Discussion
MT12 promotes dermal papilla cell proliferation and induces a Wnt/ β -catenin-related transcriptional profile consistent with pro-growth signaling, while structural analyses suggest modulation of AR conformational dynamics. These integrated cellular and computational findings support MT12 as a potential modulator of dermal papilla cell function, although AR-related activity and the causal role of Wnt/ β -catenin signaling require further validation.
Zitieren
APA
Liu, J., Wu, D., Zhou, M., Zhao, X., Mei, H., Ren, C., & Ma, Y. (2026). Myristoyl Tetrapeptide-12 promotes dermal papilla cell proliferation and modulates wnt/β-catenin signaling and androgen receptor conformational dynamics. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1996340
Vancouver
Liu J, Wu D, Zhou M, Zhao X, Mei H, Ren C, et al. Myristoyl Tetrapeptide-12 promotes dermal papilla cell proliferation and modulates wnt/β-catenin signaling and androgen receptor conformational dynamics. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1996340
BibTeX
@article{Liu2026,
author = {Liu, Jianing and Wu, Di and Zhou, Mengya and Zhao, Xia and Mei, Hexiang and Ren, Chuanpeng and Ma, Yanyun},
title = {Myristoyl Tetrapeptide-12 promotes dermal papilla cell proliferation and modulates wnt/β-catenin signaling and androgen receptor conformational dynamics},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1996340}
}
EUVIMED